Most Read Articles
4 days ago
The use of capsule endoscopy (CE) appears to be effective in the diagnosis of iron deficiency anaemia (IDA), yielding a 33.9-percent yield in this study, with 65.8 percent of patients undergoing further workup and 12.7 percent requiring therapeutic intervention.
Tristan Manalac, 3 days ago
Minimally invasive pancreatectomy (MIP) offers a feasible alternative to open pancreatectomy (OP) for the treatment of pancreatic neuroendocrine neoplasms (PNEN), according to a recent Singapore study has found.
Yesterday
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.
21 May 2020
At the 13th Annual Scientific Meeting of the Malaysian Osteoporosis Society (MOS), Dr Chan Siew Pheng discussed the role of alfacalcidol (One-Alpha®) in the treatment of osteoporosis (OP) and presented several patient profiles where alfacalcidol exhibited efficacy in increasing bone mineral density (BMD).

Pegcetacoplan yields favourable outcome in patients with geographic atrophy

29 Feb 2020

The complement C3 inhibitor pegcetacoplan appears to induce significant decreases in the growth of geographic atrophy (GA), according to data from a phase II study.

Two hundred forty-six patients with GA were randomized to receive intravitreal injections of 15-mg pegcetacoplan monthly (n=86) or every other month (EOM; n=79) or sham intravitreal injections monthly or EOM (pooled, n=81) for 12 months, with follow-up at months 15 and 18. Researchers used fundus autofluorescence imaging to measure area and growth of GA.

The primary efficacy endpoint of change from baseline to month 12 in the square root of the GA lesion area was met in both the active treatment arms. The GA growth rate decreased by 29 percent (95 percent confidence interval [CI], 9–49; p=0.008) and by 20 percent (95 percent CI, 0–40; p=0.067) in patients receiving pegcetacoplan monthly or EOM, respectively, relative to those who received sham treatment.

Posthoc analysis revealed that the beneficial effect with pegcetacoplan was greater in the second 6 months of treatment, with reductions of 45 percent (p=0.0004) in the monthly regimen and 33 percent (p=0.009) in the EOM regimen arms.

There were two cases of culture-positive endophthalmitis and a case of culture-negative endophthalmitis documented in the pegcetacoplan monthly arm. New-onset exudative age-related macular degeneration (AMD) occurred more frequently in pegcetacoplan-treated eyes (20.9 percent and 8.9 percent in monthly and EOM arms, respectively) than in sham-treated eyes (1.2 percent).

A late stage of AMD, GA is a major cause of blindness. Phase III studies should establish the safety and efficacy of local C3 inhibition with pegcetacoplan for treating GA, the researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
The use of capsule endoscopy (CE) appears to be effective in the diagnosis of iron deficiency anaemia (IDA), yielding a 33.9-percent yield in this study, with 65.8 percent of patients undergoing further workup and 12.7 percent requiring therapeutic intervention.
Tristan Manalac, 3 days ago
Minimally invasive pancreatectomy (MIP) offers a feasible alternative to open pancreatectomy (OP) for the treatment of pancreatic neuroendocrine neoplasms (PNEN), according to a recent Singapore study has found.
Yesterday
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.
21 May 2020
At the 13th Annual Scientific Meeting of the Malaysian Osteoporosis Society (MOS), Dr Chan Siew Pheng discussed the role of alfacalcidol (One-Alpha®) in the treatment of osteoporosis (OP) and presented several patient profiles where alfacalcidol exhibited efficacy in increasing bone mineral density (BMD).